← Scroll for more →
Eupraxia Pharmaceuticals Inc. (EPRX)
Pharmaceutical Preparations
Latest Price
$7.08
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.05
P/B Ratio
3.45
Institutional Ownership
44.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 3.63M | $23.0M | 6.98% | -38.6K | 2026-06-30 |
| Balyasny Asset Management L.P. | 1.35M | $8.0M | 2.60% | +15 | 2026-06-30 |
| Vivo Capital, LLC | 1.35M | $8.0M | 2.60% | -- | 2026-06-30 |
| Scotia Capital Inc. | 1.34M | $8.0M | 2.59% | +1.5K | 2026-06-30 |
| PFM Health Sciences, LP | 1.21M | $8.0M | 2.33% | +669.8K | 2026-06-30 |
| Great Point Partners LLC | 1.20M | $7.0M | 2.31% | -- | 2026-06-30 |
| Jupiter Topco LLC | 1.05M | $6.0M | 2.01% | -- | 2026-06-30 |
| Rubric Capital Management LP | 867.4K | $5.0M | 1.67% | +176.3K | 2026-06-30 |
| Ikarian Capital, LLC | 809.7K | $5.0M | 1.56% | -405.0K | 2026-06-30 |
| Woodline Partners LP | 746.9K | $4.0M | 1.44% | +306.3K | 2026-06-30 |